PO-1045 Retreatment using Ru-106 or I-125 plaque in uveal melanoma locally recurrent after brachytherapy

Tagliaferri, L. (Luca); Pagliara, M.M. (M. M.); Fionda, B. (Bruno); Scupola, A. (A.); Azario, L. (L.); Sammarco, M.G. (M. G.); Autorino, R. (R.); Lancellotta, V. (Valentina); Cammelli, S. (S.); Caputo, C.G. (C. G.); Martinez-Monge, R. (Rafael); Kovács, G. (Gyorgy); Gambacorta, M.A. (M. A.); Valentini, V. (Vincenzo); Blasius, B. (B.)

Palabras clave :

Brachytherapy
Interventional Radiotherapy
Ruthenium-106
Oncology

Fecha de publicación :

2019

Editorial :

Elsevier BV

ISSN :

0167-8140

Nota:

Under a Creative Commons license

Cita:

Tagliaferri, L. (L.); Pagliara, M.M. (M. M); Fionda, B. (B.); et al. "PO-1045 Retreatment using Ru-106 or I-125 plaque in uveal melanoma locally recurrent after brachytherapy". Radiotherapy and Oncology. 133 (1), 2019, S581

Resumen

Purpose or Objective:To present the results of a patient therapeutic approach using a second course of Interventional Radiotherapy (Brachytherapy) in a setting of patients with local recurrence of uveal melanoma. Material and Methods: Patients who had already undergone ocular brachytherapy at IOC (Interventional Oncology Center) of the “Gemelli ART” (Advanced Radiation Therapy) of Rome were considered. In this group, five patients with a local recurrence that received a second course of treatment with a plaque were included in our analysis. The reirradiation was performed with a plaque of Ruthenium-106 (dose prescribed to the apex 100 Gy) or of Iodine-125 (dose prescribed to the apex 85Gy).

URI :

https://hdl.handle.net/10171/62277

DOI:

10.1016/S0167-8140(19)31465-3

Aparece en las colecciones:

DA - CUN - Oncología radioterápica - Artículos de revista

Ficheros en este ítem: